Table 1 Information on the study subjects and the treatment conditions for the experiments.
Subject | Diagnosis | Sex | Age | HLA-DQ status | Current diet | GFD duration | tTG IgA serology* | Gluten challenge | Sample | Experiment |
|---|---|---|---|---|---|---|---|---|---|---|
CD005 | CD | F | 61 | DQ2.5/DQ2.5 | GFD | 1 yr | negative | Wheat 3d | PBMC | 1,2 |
CD006 | CD | F | 61 | DQ2.5/DQ5 | GFD | 16 yr | negative | Wheat 3d | PBMC | 1 |
CD0011 | CD | M | 55 | DQ2.5/DQ8 | GFD | 10 yr | negative | Wheat 3d | PBMC | 1 |
CD0039 | CD | F | 55 | DQ2.5/DQ2.2 | GFD | 2 yr | negative | Wheat 3d | PBMC | 1,2 |
HC014 | HC | F | 30 | DQ2.5/DQ6 | GFD | 4 wk | negative | Wheat 3d | PBMC | 1 |
HC036 | HC | F | 52 | DQ2.5/DQ6 | GFD | 4 wk | negative | Wheat 3d | PBMC | 1 |
CD037 | CD | F | 50 | DQ2.5/DQ6 | GFD | NA | negative | Wheat 3d | PBMC | 2 |
CD025 | CD | F | 25 | DQ2.5/DQ2.5 | GFD | 6 yr | negative | Barley 3d | PBMC | 2 |
CD027 | CD | F | 40 | DQ2.5/DQ2.5 | GFD | 1 yr | negative | Barley 3d | PBMC | 2 |
CD034 | CD | F | 58 | DQ2.5/DQ5 | GFD | 5 yr | negative | Rye 3d | PBMC | 2 |
CD042 | CD | F | 65 | DQ2.5/DQ5 | GFD | 27 yr | negative | Rye 3d | PBMC | 2 |
CD044 | CD | F | 64 | DQ2.5/DQ6 | GFD | 7 yr | negative | Rye 3d | PBMC | 2 |
CD1GB | CD | F | 67 | DQ2/DQ6 | AD/GFD | 1 yr | 90/neg | NA | Biopsy | 3 |
CD2GB | CD | F | 47 | DQ2/DQ6 | AD/GFD | 1 yr | 57/neg | NA | Biopsy | 3 |
CD3GB | CD | M | 56 | DQ2/DQ6 | AD /GFD | 1 yr | 21/neg | NA | Biopsy | 3 |
CD4GB | CD | F | 20 | DQ2/DQ2 | AD /GFD | 1 yr | 44/neg | NA | Biopsy | 3 |
CD5GB | CD | F | 39 | DQ2/DQ2 | AD /GFD | 1 yr | >100/neg | NA | Biopsy | 3 |
